Journal profile · Psychiatry
International Clinical Psychopharmacology
ISSN 0268-1315 · eISSN 1473-5857 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1986
International Clinical Psychopharmacology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.56; JCR Q2 (journal website); hybrid open access; median 50 days to acceptance (25 articles, last 24 months); community-reported acceptance: fairly easy; 35 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
International Clinical Psychopharmacology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Schizophrenia research and treatment, Treatment of Major Depression and Bipolar Disorder and Treatment, together about 44.9% of its articles. Its main subfields are Psychiatry and Mental health. (generated from OpenAlex topic counts and CAS ranking data)
International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes. A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds.
Source: LetPub
Research area (LetPub): Psychiatry
Editor-in-chief Alessandro SerrettiPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Schizophrenia research and treatmentMedicine17%
- Treatment of Major DepressionMedicine15.5%
- Bipolar Disorder and TreatmentMedicine12.5%
- Electroconvulsive Therapy StudiesMedicine7.9%
- Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychology6%
- Obsessive-Compulsive Spectrum DisordersPsychology3.7%
- Tryptophan and brain disordersNeuroscience3.7%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · PHARMACOLOGY & PHARMACY · rank 169/356
- JCR Q2 · PSYCHIATRY · rank 112/293
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.56LetPub ·
- Impact factor (publisher)
- 3Publisher website ·
- CiteScore 2026-06
- 5.6LetPub ·
- SJR 2026-06
- 0.78LetPub ·
- SNIP 2026-06
- 0.72LetPub ·
- h-index
- 85LetPub ·
- h-index
- 129OpenAlex ·
- i10-index
- 1,756OpenAlex ·
- 2-year mean citedness
- 3.31OpenAlex ·
- Self-citation rate
- 20%LetPub ·
- Share of gold OA articles
- 28.68%LetPub ·
Volume
- Articles per year
- 38LetPub ·
Articles by year OpenAlex count · 3,504 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 29 | 7 | 13 |
| 2025 | 35 | 9 | 68 |
| 2024 | 47 | 15 | 286 |
| 2023 | 77 | 20 | 524 |
| 2022 | 62 | 17 | 555 |
| 2021 | 42 | 12 | 490 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
50 daysMedian, submission to acceptance · P25–P75 36 days – 57 days
- Acceptance to online
- median 24 days (26 articles)
- Submission to online
- median 87 days
- Sample
- 25 articles with submission and acceptance dates (76 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1986
- ISSN
- 0268-1315
- Electronic ISSN
- 1473-5857
- Latest issue on the website
- Volume 41, Issue 5 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about International Clinical Psychopharmacology
What CAS zone is International Clinical Psychopharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Clinical Psychopharmacology is in Zone 4 of Medicine, and in Zone 3 of the minor category Pharmacology & Pharmacy / Psychiatry. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Clinical Psychopharmacology?
The latest impact factor listed by LetPub is 2.56; CiteScore 5.6, h-index 129.
How long does peer review take at International Clinical Psychopharmacology?
Based on the dates recorded on 25 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 50 days (interquartile range 36–57 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is International Clinical Psychopharmacology in?
The journal's website gives JCR Q2; by category, PHARMACOLOGY & PHARMACY Q2 (169/356), PSYCHIATRY Q2 (112/293). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index International Clinical Psychopharmacology?
According to LetPub and DOAJ records, International Clinical Psychopharmacology is indexed in SCIE and Scopus.
Is International Clinical Psychopharmacology open access, and what is the APC?
International Clinical Psychopharmacology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .